🎉 M&A multiples are live!
Check it out!

Cargo Therapeutics Valuation Multiples

Discover revenue and EBITDA valuation multiples for Cargo Therapeutics and other public comps.

See Cargo Therapeutics Valuation Multiples

Cargo Therapeutics Overview

About Cargo Therapeutics

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.


Founded

2019

HQ

United States of America
Employees

116

Website

cargo-tx.com

Financials

LTM Revenue n/a

LTM EBITDA -$168M

EV

-$211M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Cargo Therapeutics Financials

Cargo Therapeutics has a last 12-month revenue of n/a and a last 12-month EBITDA of -$168M.

In the most recent fiscal year, Cargo Therapeutics achieved revenue of n/a and an EBITDA of -$92.9M.

Cargo Therapeutics expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Cargo Therapeutics valuation multiples based on analyst estimates

Cargo Therapeutics P&L

FY 2022 FY 2023 FY 2024 LTM NTM
Revenue n/a n/a n/a n/a XXX
Gross Profit n/a n/a n/a XXX XXX
Gross Margin NaN% NaN% NaN% XXX XXX
EBITDA -$34.6M -$92.9M -$176M -$168M XXX
EBITDA Margin -Infinity% -Infinity% -Infinity% -Infinity% XXX
Net Profit -$5.8M -$41.0M -$98.1M XXX XXX
Net Margin -Infinity% -Infinity% -Infinity% XXX XXX
Net Debt n/a $20.0M n/a XXX XXX

Financial data powered by Morningstar, Inc.

Cargo Therapeutics Stock Performance

As of February 10, 2025, Cargo Therapeutics's stock price is $4.

Cargo Therapeutics has current market cap of $165M, and EV of -$211M.

See Cargo Therapeutics trading valuation data

Cargo Therapeutics Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
-$211M $165M XXX XXX XXX XXX $-3.54

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Cargo Therapeutics Valuation Multiples

As of February 10, 2025, Cargo Therapeutics has market cap of $165M and EV of -$211M.

Cargo Therapeutics's trades at n/a LTM EV/Revenue multiple, and 1.3x LTM EBITDA.

Analysts estimate Cargo Therapeutics's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Cargo Therapeutics and 10K+ public comps

Cargo Therapeutics Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV -$211M XXX XXX XXX
EV/Revenue n/a XXX XXX XXX
EV/EBITDA 1.2x XXX XXX XXX
P/E -1.0x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF 1.7x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Cargo Therapeutics Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Cargo Therapeutics Valuation Multiples

Cargo Therapeutics's NTM/LTM revenue growth is Infinity%

Cargo Therapeutics's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged $0.8M for the same period.

Over next 12 months, Cargo Therapeutics's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Cargo Therapeutics's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Cargo Therapeutics and other 10K+ public comps

Cargo Therapeutics Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth n/a XXX XXX XXX XXX
EBITDA Margin n/a XXX XXX XXX XXX
EBITDA Growth 90% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee n/a XXX XXX XXX XXX
Opex per Employee $0.8M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue n/a XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Medical Devices
Consumer SaaS
Streaming Platforms
AdTech Software
Climate Tech
GRC Software
Developer Tools

Cargo Therapeutics Public Comps

See valuation multiples for Cargo Therapeutics public comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Cargo Therapeutics M&A and Investment Activity

Cargo Therapeutics acquired  XXX companies to date.

Last acquisition by Cargo Therapeutics was  XXXXXXXX, XXXXX XXXXX XXXXXX . Cargo Therapeutics acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Cargo Therapeutics

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Cargo Therapeutics

When was Cargo Therapeutics founded? Cargo Therapeutics was founded in 2019.
Where is Cargo Therapeutics headquartered? Cargo Therapeutics is headquartered in United States of America.
How many employees does Cargo Therapeutics have? As of today, Cargo Therapeutics has 116 employees.
Who is the CEO of Cargo Therapeutics? Cargo Therapeutics's CEO is Ms. Gina Chapman.
Is Cargo Therapeutics publicy listed? Yes, Cargo Therapeutics is a public company listed on NAS.
What is the stock symbol of Cargo Therapeutics? Cargo Therapeutics trades under CRGX ticker.
When did Cargo Therapeutics go public? Cargo Therapeutics went public in 2023.
Who are competitors of Cargo Therapeutics? Similar companies to Cargo Therapeutics include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Cargo Therapeutics? Cargo Therapeutics's current market cap is $165M
What is the current EBITDA of Cargo Therapeutics? Cargo Therapeutics's last 12-month EBITDA is -$168M.
What is the current EV/EBITDA multiple of Cargo Therapeutics? Current EBITDA multiple of Cargo Therapeutics is 1.3x.
Is Cargo Therapeutics profitable? Yes, Cargo Therapeutics is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.